• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR TEXAS MENTOR MEMORYGEL BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR TEXAS MENTOR MEMORYGEL BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number 3542507
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 07/03/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a female patient underwent breast augmentation procedure with a 250cc mentor memorygel breast implant and experienced left side capsular contracture; baker grade iii.As a result, the device was explanted on an unknown date.
 
Additional Manufacturer Narrative
Photo evaluation summary: upon visual evaluation of the image provided in the complaint no apparent damage or visual anomalies were observed.Mentor concluded that the capsular contracture in the patient´s breast was the result of the body´s individual physiological response to the implantation of a foreign object in soft tissue.Capsular contracture is a known complication associated with these devices and is referenced in our current product insert data sheet.It should be noted that as part of mentor¿s quality process, all devices are manufactured, inspected, and released to approved specifications.Since no malfunction was observed during the investigation, capa activity was not required.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post market surveillance.Reason for device explant and/or reoperation: left capsular contracture; baker grade iii.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.Manufacturer¿s reference number: (b)(4).
 
Additional Manufacturer Narrative
On september 6, 2023, the mentor failure analysis lab received the device for evaluation.Following information has been updated on this form as per paperwork received with the device.Patient's initials under field a! has been updated to (b)(6).Date of birth under field a2 has been updated to (b)(6) 1976 ; month and year was received patient underwent revision breast augmentation mentor became aware that patient experienced bilateral capsular contracture; baker grade iii, and underwent bilateral replacement surgery with catalog number smpx190; serial number (b)(6) on the left side, and with catalog number smpx190; serial number (b)(6) on july 4, 2023.This supplemental report is for the left side.Right side complication is being reported separately date of explant under field d6b has been updated to (b)(6), 2023 on this form on september 8, 2023, device evaluation was completed.Device evaluation summary: mentor conducted a visual inspection of the returned device.During visual evaluation, no apparent damage or visual anomalies were observed on the gel siltex mod-rnd 250cc returned device.Mentor concluded that the capsular contracture in the patient´s breast was the result of the body´s individual physiological response to the implantation of a foreign object in soft tissue.Capsular contracture is a known complication associated with these devices and is referenced in our current product insert data sheet.It should be noted that as part of mentor¿s quality process, all devices are manufactured, inspected, and released to approved specifications.Since no malfunction was observed during the investigation, capa activity was not required.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.On september 10, 2023, mentor became aware that incorrect due date "8/12/2023" was mistakenly submitted under previous initial submission.It should have been "8/11/2023" manufacturer¿s reference number: (b)(4).Incorrect due date "8/12/2023" was mistakenly submitted under previous initial submission.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MENTOR MEMORYGEL BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
Manufacturer (Section G)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
Manufacturer Contact
kate karberg
3041 skyway circle north
irving, TX 75038
3035526892
MDR Report Key17368660
Report Number1645337-2023-08639
Device Sequence Number11708520
Product Code FTR
UDI-Device Identifier00081317000655
UDI-Public00081317000655
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
P030053
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/11/2010
Device Model Number3542507
Device Catalogue Number3542507
Device Lot Number5597548
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/13/2023
Supplement Date Received by Manufacturer09/06/2023
Initial Report FDA Received Date07/21/2023
Supplement Report FDA Received Date09/14/2023
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/12/2005
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age46 YR
Patient SexFemale
-
-